322 related articles for article (PubMed ID: 25940108)
1. A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation.
Karabon L; Markiewicz M; Partyka A; Pawlak-Adamska E; Tomkiewicz A; Dzierzak-Mietla M; Kyrcz-Krzemien S; Frydecka I
Immunogenetics; 2015 Jun; 67(5-6):295-304. PubMed ID: 25940108
[TBL] [Abstract][Full Text] [Related]
2. CTLA-4 polymorphisms: influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation.
Hammrich J; Wittig S; Ernst T; Gruhn B
J Cancer Res Clin Oncol; 2018 Mar; 144(3):587-592. PubMed ID: 29335768
[TBL] [Abstract][Full Text] [Related]
3. NOD2/CARD15 single nucleotide polymorphism 13 (3020insC) is associated with risk of sepsis and single nucleotide polymorphism 8 (2104C>T) with herpes viruses reactivation in patients after allogeneic hematopoietic stem cell transplantation.
Jaskula E; Lange A; Kyrcz-Krzemien S; Markiewicz M; Dzierzak-Mietla M; Jedrzejczak WW; Czajka P; Mordak-Domagala M; Lange J; Gronkowska A; Nowak J; Warzocha K; Hellmann A; Kowalczyk J; Drabko K; Gozdzik J; Mizia S;
Biol Blood Marrow Transplant; 2014 Mar; 20(3):409-14. PubMed ID: 24345423
[TBL] [Abstract][Full Text] [Related]
4. Pretransplant donor and recipient CTLA-4 mRNA and protein levels as a prognostic marker for aGvHD in allogeneic hematopoietic stem cell transplantation.
Karabon L; Markiewicz M; Kosmaczewska A; Partyka A; Pawlak-Adamska E; Tomkiewicz A; Ciszak L; Jagoda K; Dzierzak-Mietla M; Kyrcz-Krzemien S; Frydecka I
Immunol Lett; 2015 May; 165(1):52-9. PubMed ID: 25841352
[TBL] [Abstract][Full Text] [Related]
5. Effect of donor CTLA-4 alleles and haplotypes on graft-versus-host disease occurrence in Tunisian patients receiving a human leukocyte antigen-identical sibling hematopoietic stem cell transplant.
Sellami MH; Bani M; Torjemane L; Kaabi H; Ladeb S; Ben Othmane T; Hmida S
Hum Immunol; 2011 Feb; 72(2):139-43. PubMed ID: 21081144
[TBL] [Abstract][Full Text] [Related]
6. CTLA-4 polymorphism and clinical outcome post allogeneic hematopoietic stem cell transplantation.
Mossallam GI; Samra MA
Hum Immunol; 2013 Dec; 74(12):1643-8. PubMed ID: 23973330
[TBL] [Abstract][Full Text] [Related]
7. The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population.
Torres-Carrillo N; Ontiveros-Mercado H; Torres-Carrillo NM; Parra-Rojas I; Rangel-Villalobos H; Ramírez-Dueñas MG; Gutiérrez-Ureña SR; Valle Y; Muñoz-Valle JF
Cell Biochem Biophys; 2013; 67(3):1217-28. PubMed ID: 23703660
[TBL] [Abstract][Full Text] [Related]
8. The Influence of Genetic Variations in the
Karabon L; Markiewicz M; Chrobot K; Dzierzak-Mietla M; Pawlak-Adamska E; Partyka A; Koclega A; Kyrcz-Krzemien S; Frydecka I
J Immunol Res; 2018; 2018():3826989. PubMed ID: 29577049
[TBL] [Abstract][Full Text] [Related]
9. IL-10 promoter polymorphisms influence susceptibility to aGvHD and are associated with proportions of CD4+FoxP3+ lymphocytes in blood after hematopoietic stem cell transplantation.
Jaskula E; Lange A; Dlubek D; Kyrcz-Krzemień S; Markiewicz M; Dzierzak-Mietla M; Jedrzejczak WW; Gronkowska A; Nowak J; Warzocha K; Hellmann A; Kowalczyk J; Drabko K; Goździk J; Mizia S;
Tissue Antigens; 2013 Dec; 82(6):387-96. PubMed ID: 24498995
[TBL] [Abstract][Full Text] [Related]
10. CTLA-4 polymorphism rs231775: Influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood.
Hammrich J; Wittig S; Ernst T; Gruhn B
Eur J Haematol; 2019 Mar; 102(3):251-255. PubMed ID: 30465728
[TBL] [Abstract][Full Text] [Related]
11. Association of cytotoxic T-lymphocyte antigen-4 (CTLA-4) single nucleotide polymorphism in donors with clinical outcome after allogeneic hematopoietic stem cell transplantation: a meta-analysis.
Wang Z; Zhang Y; Du Y; Song F; Gao S
Hematology; 2021 Dec; 26(1):144-152. PubMed ID: 33491603
[TBL] [Abstract][Full Text] [Related]
12. [Relationship of tumor necrosis factor gene polymorphism and acute graft-versus-host disease after unrelated allogeneic hematopoietic stem cell transplantation].
Jin L; Xiao HW; Lai XY; Wu GQ; Luo Y; Shi JM; Tan YM; Huang H
Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):320-4. PubMed ID: 20627040
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor.
Qin XY; Wang Y; Li GX; Qin YZ; Wang FR; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Chang YJ; Liu KY; Jiang ZF; Huang XJ
J Transl Med; 2016 Apr; 14():100. PubMed ID: 27118383
[TBL] [Abstract][Full Text] [Related]
14. Influence of cytotoxic T-lymphocyte antigen-4 polymorphisms on acute rejection onset of cadaveric renal transplants.
Canossi A; Aureli A; Delreno F; Iesari S; Cervelli C; Clemente K; Famulari A; Pisani F; Papola F
Transplant Proc; 2013 Sep; 45(7):2645-9. PubMed ID: 24034013
[TBL] [Abstract][Full Text] [Related]
15. IL-6 and IL-10 promoter gene polymorphisms of patients and donors of allogeneic sibling hematopoietic stem cell transplants associate with the risk of acute graft-versus-host disease.
Karabon L; Wysoczanska B; Bogunia-Kubik K; Suchnicki K; Lange A
Hum Immunol; 2005 Jun; 66(6):700-10. PubMed ID: 15993715
[TBL] [Abstract][Full Text] [Related]
16. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
Wu J; Tang JL; Wu SJ; Lio HY; Yang YC
Clin Chim Acta; 2009 May; 403(1-2):229-33. PubMed ID: 19332044
[TBL] [Abstract][Full Text] [Related]
17. CTLA-4 +49A>G polymorphism of recipients of HLA-matched sibling allogeneic stem cell transplantation is associated with survival and relapse incidence.
Piccioli P; Balbi G; Serra M; Morabito A; Lamparelli T; Gobbi M; Laurent S; Dozin B; Bruzzi P; Ferraris AM; Bacigalupo A; Notaro R; Pistillo MP
Ann Hematol; 2010 Jun; 89(6):613-8. PubMed ID: 20020126
[TBL] [Abstract][Full Text] [Related]
18. ATM gene single nucleotide polymorphisms predict regimen-related gastrointestinal toxicity in patients allografted after reduced conditioning.
Kuba A; Raida L; Mrazek F; Schneiderova P; Kriegova E; Furst T; Furstova J; Faber E; Ambruzova Z; Papajik T
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1136-40. PubMed ID: 25759145
[TBL] [Abstract][Full Text] [Related]
19. Donor CTLA-4 genotype influences clinical outcome after T cell-depleted allogeneic hematopoietic stem cell transplantation from HLA-identical sibling donors.
Bosch-Vizcaya A; Pérez-García A; Brunet S; Solano C; Buño I; Guillem V; Martínez-Laperche C; Sanz G; Barrenetxea C; Martínez C; Tuset E; Lloveras N; Coll R; Guardia R; González Y; Roncero JM; Bustins A; Gardella S; Fernández C; Buch J; Gallardo D;
Biol Blood Marrow Transplant; 2012 Jan; 18(1):100-5. PubMed ID: 21703972
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies.
Jagasia M; Clark WB; Brown-Gentry KD; Crawford DC; Fan KH; Chen H; Kassim A; Greer JP; Engelhardt BG; Savani BN
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1069-75. PubMed ID: 22178694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
